🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 23 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/06/2016 44,59 44,86 41,70 42,71 -3,63% 7,09% 1.549.000
20/06/2016 44,71 45,21 44,04 44,32 +0,18% 2,62% 1.371.800
17/06/2016 46,11 46,77 44,08 44,24 -4,35% 5,83% 2.101.000
16/06/2016 46,29 46,29 45,16 46,25 -0,71% 2,44% 673.300
15/06/2016 46,84 47,29 45,70 46,58 +0,37% 3,39% 747.300
14/06/2016 46,57 47,33 45,72 46,41 -0,56% 3,46% 756.800
13/06/2016 47,88 48,71 46,30 46,67 -3,53% 5,03% 1.024.500
10/06/2016 49,16 49,30 47,20 48,38 -2,99% 4,27% 1.042.500
09/06/2016 51,54 53,00 49,83 49,87 -4,04% 6,15% 948.600
08/06/2016 51,27 52,13 50,00 51,97 +1,52% 4,15% 643.000
07/06/2016 51,61 51,93 50,33 51,19 -1,48% 3,10% 782.300
06/06/2016 49,65 52,16 49,00 51,96 +4,93% 6,36% 1.205.000
03/06/2016 50,75 50,99 48,34 49,52 -2,42% 5,22% 1.236.400
02/06/2016 49,51 50,84 49,02 50,75 +2,32% 3,68% 1.187.800
01/06/2016 49,29 49,98 48,52 49,60 -0,10% 2,96% 950.100
31/05/2016 48,56 50,87 48,49 49,65 +7,49% 4,90% 2.236.000
27/05/2016 46,14 46,31 45,06 46,19 +0,79% 2,71% 653.600
26/05/2016 46,47 46,47 44,41 45,83 -1,57% 4,43% 1.157.600
25/05/2016 49,06 49,44 46,01 46,56 -4,53% 6,99% 1.141.000
24/05/2016 48,57 49,21 48,28 48,77 +1,46% 1,91% 978.100
23/05/2016 48,45 48,49 47,43 48,07 +0,38% 2,19% 1.341.500
20/05/2016 46,88 48,25 46,41 47,89 +2,07% 3,92% 1.108.300
19/05/2016 45,48 47,30 45,00 46,92 +2,80% 5,06% 1.178.300
18/05/2016 43,15 46,66 43,11 45,64 +5,19% 8,23% 1.575.200
17/05/2016 45,59 45,90 43,19 43,39 -4,93% 5,94% 1.246.700
16/05/2016 43,90 46,11 43,79 45,64 +4,56% 5,28% 1.012.000
13/05/2016 42,87 44,55 42,44 43,65 +1,65% 4,92% 766.100
12/05/2016 42,98 43,28 41,67 42,94 +0,68% 3,75% 752.700
11/05/2016 44,58 44,60 42,51 42,65 -4,56% 4,69% 644.400
10/05/2016 45,50 45,50 43,60 44,69 -0,45% 4,18% 572.900